VEGFC and hepatocellular carcinoma: This study demonstrates that URG4/URGCP may promote angiogenesis and the expression of VEGF-C in HCC by activating the NF-κB signaling pathway; therefore, URG4/URGCP may have potential as a therapeutic target in HCC.